BFM
SCMP

Boothbay Fund Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Boothbay Fund Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-332,075
Closed -$5.96M – 991
2017
Q4 		$5.96M Buy
+332,075
New +$4.09M 0.87% 25
2016
Q2 		– Sell
-10,398
Closed -$114K – 641
2016
Q1 		$114K Buy
+10,398
New +$131K 0.09% 257

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Boothbay Fund Management's SCMP Position: Q1 2018 in Review

Boothbay Fund Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 332,075 shares — an estimated $5.96M sold.

Boothbay Fund Management first reported a position in SCMP in Q1 2016 and held it in 2 quarters. The position peaked at $5.96M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Boothbay Fund Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Boothbay Fund Management sold 332,075 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $5.96M.
  • Boothbay Fund Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2016 and held it in 2 quarters.
  • Boothbay Fund Management's Sucampo Pharmaceuticals, Inc. position peaked at $5.96M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Boothbay Fund Management's 13F filing for Q1 2018, filed 14 May 2018.